| Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye (NCT01217398) | Institut Curie | 2009-10-01 |
| Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye (NCT00952939) | Case Comprehensive Cancer Center | 2009-03-01 |
| Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery (NCT00471471) | Ahmad Tarhini | 2008-10-01 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery (NCT00738361) | Ohio State University Comprehensive Cancer Center | 2008-08-01 |
| Vaccine Therapy in Treating Patients With Advanced Melanoma (NCT00705640) | Craig L Slingluff, Jr | 2008-05-01 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom (NCT00757614) | Cancer Research UK | 2008-02-01 |
| Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma (NCT00897624) | Institut Curie | 2007-11-01 |
| Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma (NCT00489944) | San Diego Pacific Oncology & Hematology Associates | 2007-05-01 |
| Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation (NCT00471133) | Ichor Medical Systems Incorporated | 2007-04-01 |
| Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma (NCT00482911) | National Institutes of Health Clinical Center (CC) | 2007-04-01 |
| Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma (NCT00398073) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Dendritic Cell Vaccination During Lymphoid Reconstruction (NCT00313508) | H. Lee Moffitt Cancer Center and Research Institute | 2006-02-01 |
| AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma (NCT00243061) | National Cancer Institute (NCI) | 2006-01-01 |
| Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma (NCT00110123) | European Organisation for Research and Treatment of Cancer - EORTC | 2005-01-01 |
| Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma (NCT00084656) | Bristol-Myers Squibb | 2004-05-31 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00334776) | University of Southern California | 2003-10-01 |
| Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma (NCT00072345) | Memorial Sloan Kettering Cancer Center | 2003-07-01 |
| Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma (NCT00089219) | University of Virginia | 2003-07-01 |
| Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00058279) | National Cancer Institute (NCI) | 2003-02-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery (NCT00089206) | University of Virginia | 2002-08-01 |
| Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma (NCT00031733) | University of Southern California | 2002-02-01 |
| Vaccine Therapy in Treating Patients With Melanoma of the Eye (NCT00036816) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-02-01 |
| Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery (NCT00025181) | University of Southern California | 2001-10-01 |
| Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma (NCT00027742) | Memorial Sloan Kettering Cancer Center | 2001-05-01 |
| PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma (NCT00238329) | Barbara Ann Karmanos Cancer Institute | 2001-01-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00005841) | University of Southern California | 2000-06-01 |
| Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma (NCT00003802) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-02-01 |
| Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma (NCT00003339) | University of Southern California | 1998-11-01 |
| Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer (NCT00003022) | Memorial Sloan Kettering Cancer Center | 1997-04-01 |
| Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer (NCT00002947) | Yale University | 1996-10-01 |